Marc Siler

Writing 39C
The Strategies to Address Antimicrobial
Resistance Act
(STAAR Act)
1. Decrease in R & D
2. Drug Misuse
3. No Surveillance
4. Lack of Understanding
10x20 Initiative (IDSA)
Increase R&D programs
10 new antibiotics by 2020
However
Lengthy process
Very Costly
No guarantees of new drugs

10x20 Initiative (IDSA)
Increase R&D programs
10 new antibiotics by 2020
However
Lengthy process
Very Costly
No guarantees of new drugs
The Strategies to Address
Antimicrobial Resistance
Act

(S.2236)
Objectives
Antimicrobial Resistance Office
Antimicrobial Task Force
Advisory Board

Increase efforts of surveillance
Collecting data

Strategic research plans

Costs
$600 million
If ineffective, lost time
Social, Medical, Political
Feasibility
Initial Challenges
- Compliance
Possible
The Strategies to Address
Antimicrobial Resistance
Act

(S.2236)
Works Cited
Antibiotic Resistance Threats. Rep. Center for Disease Control and Prevention, n.d.
Web. <http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-
2013-508.pdf>.
Antibiotic Resistance Timeline. Digital image. N.p., n.d. Web. 28 May 2014.
Bad Bugs, No Drugs. Rep. N.p.: n.p., n.d. Infectious Diseases Society of America,
July 2004. Web. 13 Apr. 2014.
Cancer Awareness Ribbon. Digital image. N.p., n.d. Web. 28 May 2014.
HIV Awareness Ribbon. Digital image. N.p., n.d. Web. 28 May 2014.
National Obesity Awareness Week Logo. Digital image. N.p., n.d. Web. 28 May
2014
Red X. Digital image. N.p., n.d. Web. 28 May 2014.
Strategies to Address Antimicrobial Resistance, S. 2236, 113th Cong. (2014). Print.
"The 10 20 Initiative: Pursuing a Global Commitment to Develop 10 New
Antibacterial Drugs by 2020." Clinical Infectious Diseases 50.8 (2010): 1081-
083. Clinical Infectious Diseases. Oxford Journals, 19 Feb. 2010. Web. 7 May 2014.